Skip to main content
SpringerLink
Log in

Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Rats given a single intraperitoneal injection of an aqueous suspension of peptidoglycan-polysaccharide polymers derived from group A streptococcal cell wall (PG-APS) develop a severe, chronic, erosive arthritis which resembles human rheumatoid arthritis. The treatment of PG-APS-mjected rats with a single intravenous injection of 0.4 mg of mutanolysin prevents the development of chronic arthritis, even when administration of the enzyme is delayed until severe acute arthritis has developed. PG-APS activates complement both in vitro and in vivo. Digestion of PG-APS with mutanolysin in vitro destroys the ability to activate both the alternate and classical pathways of human serum complement, and the loss of complement activation parallels the extent of PG-APS degradation. There is also a reduction in the in vivo complexing of C3 with PG-APS in the limbs of PG-APS-injected rats treated with mutanolysin, compared to control rats injected with PG-APS and treated with phosphate-buffered saline. This association between loss of arthropathic activity and loss of activation of complement is consistent with the hypothesis that activated complement products form a part of the inflammatory mediators involved in the acute and chronic phases of bacterial cell wall-induced arthritis. This may also partially explain how mutanolysin treatment alleviates cell wall-induced arthritis in the rat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cromartie, W. J., J. G. Craddock, J. H. Schwab, S. K. Anderle, andC. Yang, 1977. Arthritis in rats after systemic injection of streptococcal cells or cell walls.J. Exp. Med. 146:1585–1602.

    Google Scholar 

  2. Dalldorf, F. G., W. J. Cromartie, S. K. Anderle, R. L. Clark, andJ. H. Schwab. 1980. The relation of experimental arthritis to the distribution of streptococcal cell wall fragments.Am. J. Pathol. 100:383–402.

    Google Scholar 

  3. Clark, R. L., J. T. Cuttino, S. K. Anderle, W. J. Cromartie, andJ. H. Schwab. 1979. Radiologic analysis of arthritis in rats after systemic injection of streptococcal ceil walls.Arthritis Rheum. 22:25–35.

    Google Scholar 

  4. Spitznagel, J. K., K. J. Goodrum, andD. J. Warejcka. 1983. Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.Am. J. Pathol. 112:37–47.

    Google Scholar 

  5. Wilder, R. L., G. B. Calandra, A. J. Garvin, K. D. Wright, andC. T. Hansen. 1982. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat.Arthritis Rheum. 25:1064–1072.

    Google Scholar 

  6. Fox, A., R. R. Brown, S. K. Anderle, C. Chetty, W. J. Cromartie, H. Gooder, andJ. H. Schwab. 1982. Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls.Infect. Immun. 35:1003–1010.

    Google Scholar 

  7. Chetty, C., D. G. Klapper, andJ. H. Schwab. 1982. Soluble peptiodoglycan-polysaccharide fragments of the bacterial cell wall induce acute inflammation.Infect. Immun. 38:1010–1119.

    Google Scholar 

  8. Janusz, M. I., C. Chetty, R. A. Eisenberg, W. J. Cromartie, andJ. H. Schwab, 1984. Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin.J. Exp. Med. 160:1360–1374.

    Google Scholar 

  9. Greenblatt, J., R. J. Boackle, andJ. H. Schwab, 1978. Activation of the alternate complement pathway by pepetidoglycan from streptococcal cell wall.Infect. Immun. 19:296–303.

    Google Scholar 

  10. Forgren, A., andP. G. Quie. 1974. Influence of the alternate complement pathway on opsonization of several bacterial species.Infect. Immun. 10:402–404.

    Google Scholar 

  11. Kotani, S., H. Takada, M. Tsujimoto, T. Ogawa, K. Kato, T. Ohunaga, Y. Ishihama, A. Kawasaki, I. Morisali, N. Kono, T. Shimono, T. Shiba, S. Kusumoto, M. Image, K. Harada, T. Kitaura, S. Kano, S. Inai, K. Nagai, M. Matsumoto, T. Kubo, M. Kato, Z. Tada, K. Yokogawa, S. Kawata, andA. Inoul. 1981. Immunomodulating and related biological activities of bacterial cell walls and their components, enzymatically prepared or synthesized.In Immunomodulation by Bacteria and Their Products. H. Friedman, T. W. Klein, and A. Szentivanyi, editors. Plenum Press, New York. 231–273.

    Google Scholar 

  12. McBride, W. H., P. M. Weir, A. B. Kay, P. Pearce, andJ. R. Caldwell. 1975. Activation of the classical and alternative pathways of complement byC. parvum.Clin. Exp. Immunol. 19:143–147.

    Google Scholar 

  13. Tauber, J. W., M. J. Polley, andJ. B. Zabriskie. 1976. Non specific complement activation by streptococcal structures II. Properdin-independent initiation of the alternate pathway.J. Exp. Med. 143:1352–1366.

    Google Scholar 

  14. Winklestein, J., andA. Tomasz. 1977. Activation of the alternative pathway by pneumocoiccal cell wall.J. Immunol. 118:451–454.

    Google Scholar 

  15. Lambris, J. D., J. B. Allen, andJ. H. Schwab. 1982. In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.Infect. Immun. 35:377–380.

    Google Scholar 

  16. Schwab, J. H., J. B. Allen, S. K. Anderle, F. Dalldorf, R. Eisenberg, andW. J. Cromartie. 1982. Relationships of complement to experimental arthritis induced in rats with streptococcal cell walls.Immunology 46:83–88.

    Google Scholar 

  17. Kotani, S. A. Kawasaki, S. Inai, K. Nagaki, M. Matsumoto, T. Shiba, S. Kusumoto, M. Inage, K. Yokogawa, S. Kawata, andA. Inoue. 1980. Activation of human complement system by enzymatic digests of bacterial cell wall peptidoglycans and 6-O-acyl-muramyl peptides.Int. J. Immunopharmacol. 2:213.

    Google Scholar 

  18. Siegel, J., S. Hurst, E. Libermann, S. Coleman, andA. Bleiweis. 1981. Mutanolysininduced spenoplasts ofStreptococcus mutans are true protoplasts.Infect. Immun. 31:808–815.

    Google Scholar 

  19. Stimpson, S. A., R. R. Brown, D. G. Klapper, W. J. Cromartie, andJ. H. Schwab. 1986. Arthropathic properties of cell wall polymers from normal flora bacteria.Infect Immun. 51:240–249.

    Google Scholar 

  20. Dische, Z., andL. B. Shettles. 1948. A specific color reaction of methyl pentose and a spectrophotometric micromethod for their determination.J. Biol. Chem. 175:595–603.

    Google Scholar 

  21. Sawardeker, J. S., J. H. Sloneker, andA. Jeanes. 1965. Quantitative determination of monosaccharides as their alditol acetates by gas-liquid chromatography.Anal. Chem. 37:1602–1604.

    Google Scholar 

  22. Klapper, D. G. 1982. A new low cost, fully automated amino acid analyzer using a gradient HPLC.In Methods in Protein Sequence Analyses. M. Elzinga, editor. Humana Press, Clifton, New Jersey. 509–515.

    Google Scholar 

  23. Platts-Mills, T.A.E., andK. Ishizaka. 1974. Activation of the alternative pathway of human complement of rabbit cells.J. Immunol. 113:348–358.

    Google Scholar 

  24. Keystone, E. C., H. V. Schlorlemmer, C. Pope, andA. C. Allison. 1977. Zymosan-induced arthritis. A model of chronic poliferative arthritis following activation of the alternative pathway of complement.Arthritis Rheum. 20:1396–1401.

    Google Scholar 

  25. Schlorlemmer, H. V., H. V. Bitter-Suermann, andA. C. Allison 1977. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.Immunology 32:929–940.

    Google Scholar 

  26. Ruddy, S., andK. F. Austen. 1970. The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.Arthritis Rheum. 13:713–723.

    Google Scholar 

  27. Hugli, T. E. 1981. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a anaphylatoxins.Crit. Rev. Immunol. 1:321–366.

    Google Scholar 

  28. Hugli, T. E., andE. J. Muller-Eberhard. 1978. Anaphylatoxins: C3a and C5a.Adv. Immunol. 26:1–53.

    Google Scholar 

  29. Snyderman, R., andE. J. Goetzl. 1981. Molecular and cellular mechanisms of leukocyte chemotaxis.Science 213:830–837.

    Google Scholar 

  30. Ward, P. A., andL. J. Newman, 1969. A neutrophil chemotactic factor from human C5a.J. Immunol. 102:93–99.

    Google Scholar 

  31. Fernandez, H. N., P. N. Henson, A. Otani, andT. E. Hugli. 1978. Chemotactic responses to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions.J. Immunol. 120:109–115.

    Google Scholar 

  32. Larsen, G. L., andP. M. Henson. 1983. Mediators of Inflammation.In Annual Review of Immunology. W. Paul, C. G. Fathman, and H. Metzger, editors. Annual Reviews, Inc., Palo Alto, California.

    Google Scholar 

  33. Regal, J. F., andR. J. Pickering. 1981. C5a-induced tracheal contraction: Effect on an SRS-A antagonist and inhibitors of arachidonate metabolism.J. Immunol. 126:313–316.

    Google Scholar 

  34. Stimler, N. P., M. K. Bach, C. M. Bloor, andT. Hugli. 1982. Release of leukotrienes from guinea pig lung stimulated by C5a des arg anaphylatoxin.J. Immunol. 128:2247–2252.

    Google Scholar 

  35. Stimler, N. P., W. E. Brocklehurst, C. M. Bloor, andT. Hugli. 1981. Anaphylatoxinmediated contraction of guinea pig lung strips: A nonhistamine tissue response.J. Immunol. 126:2258–2261.

    Google Scholar 

  36. Chenoweth, D. E., M. G. Goodman, andW. O. Weigle. 1982. Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.J. Exp. Med. 156:68–78.

    Google Scholar 

  37. Scrouzer, C. A., W. A. Scott, A. L. Hamill, andZ. A. Cohn. 1982. Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages.J. Exp. Med. 155:720–733.

    Google Scholar 

  38. Fearon, D. T., andW. Wong. 1983. Complement ligand-receptor interactions that mediate biological responses.In Annual Review of Immunology, W. Paul, C. G., Fathman, andH. Metzger, editors. Annual Reviews, Inc., Palo Alto, California. 243–271.

    Google Scholar 

  39. Dahlen, S.-E., J. Bjork, P. Hedquist, K.-E. Arfors, S. Hammarstrom, J.-A. Lindgren, andB. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: In vivo effects with relevance to the acute inflammatory response.Proc. Natl. Acad Sci. U.S.A. 78:3887–3891.

    Google Scholar 

  40. Allison, A. C. 1984. Role of macrophage activation in the pathogenesis of chronic inflammation and its pharmalogical control.In Advances in Inflammation Research, Vol. 7. 1. Overness, R. Capetola, and S. Wong, editors. Raven Press, New York, 201–221.

    Google Scholar 

  41. Schorlemmer, H. V., andA. C. Allison. 1976. Effects of activated complement components on enzyme secretion by macrophages.Immunology 31:781–788.

    Google Scholar 

  42. McCarthy, K., andP. M. Henson. 1979. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg.J. Immunol. 123:2511–2517.

    Google Scholar 

  43. Leong, P. A., J. H. Hwab, andM. S. Cohen. 1984. Interaction of group A streptococcal peptidoglycan polysaccharide with human polymorphonuclear leukocytes: Implications for pathogenesis of chronic inflammation.Infect. Immun. 45:160–165.

    Google Scholar 

  44. Pryzwansky, K. B., E. K. MaCrae, andJ. D. Lambris. 1983. Capping of complement receptors on human neutrophils induced by group A streptococcal cell walls.J. Immunol. 130:1674–1677.

    Google Scholar 

  45. Goldstein, I., D. Roos, H. B. Kaplan, andG. Weissman. 1975. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.J. Clin. Invest. 56:1155–1163.

    Google Scholar 

  46. Burger, R., V. Hadding, H. V. Schlorlemmer, V. Brade, andD. Bitter-Suermann. 1975. Dextran sulfate: A synthetic activator of C3 via the alternate pathway. I. Influence of molecular size and degree of sulfation on the activation potency.Immunology 29:549–554.

    Google Scholar 

  47. Janusz, M. J., R. E. Esser, andJ. H. Schwab. 1986. In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.Infect. Immun. 52:459–467.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, University of North Carolina, 27514, Chapel Hill, North Carolina

    M. J. Janusz, R. A. Eisenberg & J. H. Schwab

  2. Department of Medicine, School of Medicine, University of North Carolina, 27514, Chapel Hill, North Carolina

    R. A. Eisenberg

Authors
  1. M. J. Janusz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Eisenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. H. Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janusz, M.J., Eisenberg, R.A. & Schwab, J.H. Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro. Inflammation 11, 73–85 (1987). https://doi.org/10.1007/BF00917773

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917773

Keywords

Search

Navigation